Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Profit & Loss
Divis Laboratories Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value(
)
532488
INE361B01024
474.522963
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
DIVISLAB
76.42
104234.91
EPS(TTM)
Face Value(
)
Div & Yield %:
51.38
2
0.76
Particulars(INCOME)
Mar 2023
(
Cr)
Mar 2022
(
Cr)
Mar 2021
(
Cr)
Mar 2020
(
Cr)
Mar 2019
(
Cr)
Mar 2018
(
Cr)
Sales Turnover
7625.30
8879.82
6798.61
5310.57
4879.66
3837.23
Excise Duty
0.00
0.00
0.00
0.00
0.00
21.29
Net Sales
7625.30
8879.82
6798.61
5310.57
4879.66
3815.94
Other Income
349.01
111.26
62.53
189.86
156.58
112.48
Stock Adjustments
-50.16
449.99
100.00
94.10
244.22
19.38
Total Income
7924.15
9441.07
6961.14
5594.53
5280.46
3947.80
EXPENDITURE :
Raw Materials
3035.02
3499.18
2416.47
2223.95
2120.64
1524.28
Power & Fuel Cost
496.61
390.05
319.15
280.73
248.78
228.73
Employee Cost
953.05
926.55
808.68
608.36
530.72
446.27
Other Manufacturing Expenses
284.62
255.38
202.29
184.36
138.96
158.57
Selling & Administrative Expenses
402.01
340.16
292.53
222.86
171.84
201.99
Miscellaneous Expenses
54.98
40.95
37.69
68.00
62.87
23.87
Less : Pre-operative Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
5226.29
5452.27
4076.81
3588.26
3273.81
2583.71
Operating Profit
2697.86
3988.80
2884.33
2006.27
2006.65
1364.09
Interest
1.69
1.73
1.81
7.03
4.61
2.31
Gross Profit
2696.17
3987.07
2882.52
1999.24
2002.04
1361.78
Depreciation
342.07
310.55
254.65
185.95
168.81
142.42
Profit Before Tax
2354.10
3676.52
2627.87
1813.29
1833.23
1219.36
Tax
437.58
637.20
609.05
387.79
472.45
287.13
Fringe Benefit tax
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax
108.37
90.78
64.10
52.79
28.13
62.65
Reported Net Profit
1808.15
2948.54
1954.72
1372.71
1332.65
869.58
Extraordinary Items
-0.87
-1.65
-2.45
41.46
18.78
-2.55
Adjusted Net Profit
1809.02
2950.19
1957.17
1331.25
1313.87
872.13
Adjustment below Net Profit
2.33
2.18
0.16
-92.52
-53.52
-53.37
P & L Balance brought forward
9967.53
7588.31
5814.44
5636.87
4761.92
4076.94
Statutory Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
856.45
571.50
181.01
1102.62
404.18
131.23
P & L Balance carried down
10921.56
9967.53
7588.31
5814.44
5636.87
4761.92
Dividend
0.00
0.00
0.00
424.75
0.00
265.47
Preference Dividend
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend %
1500.00
1500.00
1000.00
800.00
800.00
500.00
Dividend Per Share(Rs)
30.00
30.00
20.00
16.00
16.00
10.00
Earnings Per Share-Unit Curr
68.12
111.08
73.64
51.71
50.20
32.76
Earnings Per Share(Adj)-Unit Curr
68.12
111.08
73.64
51.71
50.20
32.76
Book Value-Unit Curr
478.64
440.44
349.28
275.63
262.70
224.51
Book Value(Adj)-Unit Curr
478.64
440.44
349.28
275.63
262.70
224.51